2015
Genomic Characterization of Two Novel HIV-1 Second-Generation Recombinant Forms Among Men Who Have Sex with Men in Beijing, China
Li Z, Wei H, Feng Y, Li J, Kalish ML, Lu H, Yin L, Liao L, Qian HZ, Frost SD, Ruan Y, Vermund SH, Shao Y, Xing H. Genomic Characterization of Two Novel HIV-1 Second-Generation Recombinant Forms Among Men Who Have Sex with Men in Beijing, China. AIDS Research And Human Retroviruses 2015, 31: 342-346. PMID: 25495675, PMCID: PMC4348344, DOI: 10.1089/aid.2014.0307.Peer-Reviewed Original Research
2001
Development and Characterization of a Molecular Viability Assay for Pneumocystis carinii f sp hominis
Maher N, Vermund S, Welsh D, Dillon H, Awooda A, Unnasch T. Development and Characterization of a Molecular Viability Assay for Pneumocystis carinii f sp hominis. The Journal Of Infectious Diseases 2001, 183: 1825-1827. PMID: 11372040, DOI: 10.1086/320738.Peer-Reviewed Original ResearchConceptsPneumocystis carinii pneumoniaHuman immunodeficiency virus-infected personsP. cariniiCommon opportunistic infectionVirus-infected personsCarinii pneumoniaOpportunistic infectionsPerson transmissionHuman P. cariniiClinical specimensTransmission dynamicsCariniiInfectionViability assaysMolecular viabilityImportance of personPneumoniaReliable methodEpidemiologyPersons
2000
Development and Evaluation of a Molecular Viability Assay for Pneumocystis carinii
Maher N, Vermund S, Lasbury M, Lee C, Bartlett M, Unnasch T. Development and Evaluation of a Molecular Viability Assay for Pneumocystis carinii. Journal Of Clinical Microbiology 2000, 38: 1947-1952. PMID: 10790126, PMCID: PMC86630, DOI: 10.1128/jcm.38.5.1947-1952.2000.Peer-Reviewed Original ResearchConceptsPneumocystis carinii pneumoniaRespiratory specimensP. cariniiViable trophozoitesPatient respiratory specimensP. carinii DNAOpportunistic illnessesViability assaysCarinii pneumoniaPCP patientsShock protein 70 familyReverse transcription-PCRHeat shock protein 70 familyPneumocystis cariniiNoninvasive techniqueCarinii DNACariniiTranscription-PCREthidium bromide stainingOptimal assay conditionsTrophozoitesBromide stainingAssaysMolecular viabilitySpecific primers
1998
Immunological and Virological Analyses of Persons Infected by Human Immunodeficiency Virus Type 1 while Participating in Trials of Recombinant gp120 Subunit Vaccines
Connor RI, Korber B, Graham BS, Hahn BH, Ho DD, Walker BD, Neumann AU, Vermund SH, Mestecky J, Jackson S, Fenamore E, Cao Y, Gao F, Kalams S, Kunstman KJ, McDonald D, McWilliams N, Trkola A, Moore JP, Wolinsky SM. Immunological and Virological Analyses of Persons Infected by Human Immunodeficiency Virus Type 1 while Participating in Trials of Recombinant gp120 Subunit Vaccines. Journal Of Virology 1998, 72: 1552-1576. PMID: 9445059, PMCID: PMC124637, DOI: 10.1128/jvi.72.2.1552-1576.1998.Peer-Reviewed Original ResearchMeSH KeywordsAIDS VaccinesAmino Acid SequenceHIV Envelope Protein gp120HIV InfectionsHIV-1HumansMolecular Sequence DataRecombinant ProteinsVaccines, SyntheticConceptsHuman immunodeficiency virus type 1Immunodeficiency virus type 1Virus type 1MN rgp120Antibody responseHIV-1Recombinant gp120 subunit vaccinePhase I/II clinical trialsCytotoxic T lymphocyte responsesType 1Immunoglobulin G antibody responseGp120 subunit vaccineSyncytium-inducing (SI) phenotypeT lymphocyte responsesG antibody responseClade B virusesInducing (NSI) phenotypeInfected vaccineesNSI strainsPlacebo recipientsVaccine recipientsViral burdenPlacebo vaccineAntibody titersMultiple immunizationsAnalysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines
Graham B, McElrath M, Connor R, Schwartz D, Gorse G, Keefer M, Mulligan M, Matthews T, Wolinsky S, Montefiori D, Vermund S, Lambert J, Corey L, Belshe R, Dolin R, Wright P, Korber B, Wolff M, Fast P, Group A. Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines. The Journal Of Infectious Diseases 1998, 177: 310-309. PMID: 9466516, DOI: 10.1086/514209.Peer-Reviewed Original ResearchMeSH KeywordsAdultAIDS VaccinesAmino Acid SequenceCD4 Lymphocyte CountFemaleHIV AntibodiesHIV Envelope Protein gp120HIV InfectionsHIV-1HumansImmunity, ActiveIncidenceMaleMiddle AgedMolecular Sequence DataNeutralization TestsPeptide FragmentsRisk-TakingSequence AnalysisSubstance Abuse, IntravenousViral LoadConceptsHIV-1 infectionHuman immunodeficiency virus type 1 (HIV-1) infectionVirus type 1 infectionCandidate AIDS vaccinesType 1 infectionAIDS vaccinePhase IHigh-risk sexual exposureVaccine-induced immune responsesComplete immunization scheduleEarly clinical courseCD4 lymphocyte countIntravenous drug useV3 loop amino acid sequencesUninfected subjectsVaccine recipientsLymphocyte countClinical courseImmunization scheduleSexual exposureVirus loadImmune responseControl groupDrug useInfection
1992
Association of Mycoplasma and Human Immunodeficiency Virus Infection: Detection of Amplified Mycoplasma fermentans DNA in Blood
Hawkins R, Rickman L, Vermund S, Carl M. Association of Mycoplasma and Human Immunodeficiency Virus Infection: Detection of Amplified Mycoplasma fermentans DNA in Blood. The Journal Of Infectious Diseases 1992, 165: 581-585. PMID: 1538164, DOI: 10.1093/infdis/165.3.581.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionM. fermentans infectionImmunodeficiency virus infectionVirus infectionHIV clinical stageMycoplasma fermentans infectionHIV-seronegative subjectsHIV-seropositive patientsCross-sectional studyHistory of syphilisAssociation of MycoplasmaHIV infectionOpportunistic infectionsClinical stageLower riskNonsignificant trendPolymerase chain reaction methodologyInfectionPatientsBloodM. fermentansAssociationCopathogensHIVSyphilis
1991
Human papillomavirus infection and other risk factors for cervical neoplasia: A case‐control study
Morrison E, Ho G, Vermund S, Goldberg G, Kadish A, Kelley K, Burk R. Human papillomavirus infection and other risk factors for cervical neoplasia: A case‐control study. International Journal Of Cancer 1991, 49: 6-13. PMID: 1874571, DOI: 10.1002/ijc.2910490103.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsBase SequenceBlotting, SouthernCarcinomaCase-Control StudiesEpitheliumFemaleHumansMolecular Sequence DataMultivariate AnalysisOligonucleotidesPolymerase Chain ReactionRegression AnalysisRisk FactorsSocioeconomic FactorsTumor Virus InfectionsUterine Cervical DiseasesUterine Cervical NeoplasmsConceptsSquamous intraepithelial lesionsCervical squamous intraepithelial lesionsIndependent risk factorHPV infectionRisk factorsHigh riskCervical neoplasiaMajor independent risk factorLow educational achievementHuman papillomavirus infectionAssociation of HPVHPV types 16Major risk factorCase-control studyLogistic regression analysisCase-control designLogistic regression modelsRisk of diseaseHPV screeningIntraepithelial lesionsPapillomavirus infectionHPV typesViral loadBorderline significanceNormal women